Viewing Study NCT06225804


Ignite Creation Date: 2025-12-24 @ 9:17 PM
Ignite Modification Date: 2025-12-25 @ 7:05 PM
Study NCT ID: NCT06225804
Status: RECRUITING
Last Update Posted: 2024-03-18
First Post: 2024-01-04
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Study to Assess Safety, Tolerability, and Pharmacokinetics of ABSK112 in Patients With Non-Small Cell Lung Cancer
Sponsor: Abbisko Therapeutics Co, Ltd
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module